William E. Rote, Senior Vice President, R&D at Travere Therapeutics, Inc. (TVTX), sold 3,125 shares at $19.14 ($60K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Scheduled sale ($60k) by Senior Vice President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.14 | 1,563 | $30K | 49.6% |
| 2 | $19.46 | 1,562 | $30K | 50.4% |
| Total | $19.30 avg | 3,125 | $60K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |